Cross-Study Surveillance: Detecting Patterns Across Portfolios
Cross-Study Surveillance: Detecting Patterns Across Portfolios Cross-Study Surveillance: Detecting Patterns Across Portfolios In clinical research, the successful management of multiple studies as part of a wider portfolio can significantly influence drug development timelines and costs. This article outlines a structured approach to cross-study surveillance, providing clinical operations, regulatory affairs, and medical affairs professionals with insights…
Read More “Cross-Study Surveillance: Detecting Patterns Across Portfolios” »